Last checked at IN BRIEF: ValiRx inks evaluation agreement for breast cancer treatment
IN BRIEF: ValiRx inks evaluation agreement for breast cancer treatment
16 Sep 21 18:19
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Valirx Share News (VAL)
VAL Share
Price
VAL Share
News
VAL Share
Chat3
VAL Share
Trades583
VAL
Live RNS
VAL Share
Charts
VAL Level 2
Console
VAL Live
Share Price
VAL Broker
Ratings
VAL Directors
Deals
VAL Financial
Diary
VAL
Fundamentals
VAL Short
Positions
VAL
Media
VAL Information
Share Price Information for Valirx (VAL)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
54.50
Bid:
53.00
Ask:
54.50
Change:
-0.25
(-0.46%)
Spread:
1.50 (2.83%)
Open:
55.50
High:
54.50
Low:
54.50
Yest. Close:
54.75
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.16 Sep 21 18:19EARNINGS UPDATES: ValiRx reports narrowed loss; McBride revenue slips
EARNINGS UPDATES: ValiRx reports narrowed loss; McBride revenue slips
7 Sep 21 15:05ValiRx adds three new patents in first half
(Sharecast News) - Clinical-stage drug development company ValiRx updated the market on its patent portfolio on Tuesday, reporting that it had continued to build its intellectual property position in the first half of the year.
6 Jul 21 13:00TRADING UPDATES: Brave Bison, Strix Group see strong performances
TRADING UPDATES: Brave Bison, Strix Group see strong performances
27 May 21 20:17ValiRx terminates peptide drug candidate deal
(Sharecast News) - Clinical-stage drug development company ValiRx announced on Thursday that it has ended its agreement over the evaluation of the 'KTH222' peptide as a drug candidate for treating patients with ovarian cancer.
27 May 21 13:54UK shareholder meetings calendar - next 7 days
UK shareholder meetings calendar - next 7 days
20 May 21 16:07EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo
EXECUTIVE CHANGES: Ex-Coca-Cola exec, Cafe Rouge founder for Deliveroo
28 Apr 21 15:30TRADING UPDATES: Focusrite sales soar; Gaming Realms in Slingo boost
TRADING UPDATES: Focusrite sales soar; Gaming Realms in Slingo boost
27 Apr 21 11:32Physiomics and ValiRx enter new collaboration deal
(Sharecast News) - Oncology consulting company Physiomics has entered into a new agreement with clinical-stage drug development company ValiRx, it announced on Monday, superseding the agreement between the two companies, which was announced in September 2011.
15 Feb 21 16:04IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics
IN BRIEF: ValiRx Extends Collaboration Agreement With Physiomics
15 Feb 21 11:05IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer
IN BRIEF: ValiRx's VAL201 Patented For Treatment Of Metastatic Cancer
19 Jan 21 16:53UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter
UK TRADING UPDATE SUMMARY: Newly-Listed Wheaton Reports Bumper Quarter
10 Nov 20 17:40UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges
UK TRADING UPDATE SUMMARY: Joules In Lockdown Hit But Online Surges
23 Sep 20 19:09ValiRx Loss Narrows In First Half Amid Reduction In Expenses
ValiRx Loss Narrows In First Half Amid Reduction In Expenses
7 Sep 20 11:55IN BRIEF: ValiRx Raises GBP300,700 From Broker Option
IN BRIEF: ValiRx Raises GBP300,700 From Broker Option
24 Jul 20 17:23